Mesoblast (MEOBF) Other Non-Current Liabilities (2017 - 2025)

Mesoblast (MEOBF) has disclosed Other Non-Current Liabilities for 8 consecutive years, with $5.7 million as the latest value for Q2 2025.

  • Quarterly Other Non-Current Liabilities fell 46.1% to $5.7 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Jun 2025, down 46.1% year-over-year, with the annual reading at $5.7 million for FY2025, 46.1% down from the prior year.
  • Other Non-Current Liabilities hit $5.7 million in Q2 2025 for Mesoblast, down from $10.6 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $10.6 million in Q2 2024 to a low of $2.2 million in Q2 2022.
  • Historically, Other Non-Current Liabilities has averaged $6.0 million across 4 years, with a median of $5.6 million in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 148.33% in 2023 and later plummeted 46.1% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $2.2 million in 2022, then surged by 148.33% to $5.4 million in 2023, then soared by 95.72% to $10.6 million in 2024, then tumbled by 46.1% to $5.7 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for MEOBF at $5.7 million in Q2 2025, $10.6 million in Q2 2024, and $5.4 million in Q2 2023.